TABLE 1.

Recommendations of the WG

	Recommendation
1	Support current measures (and develop innovative new ones) to prevent future drug shortages at the national level
2	Optimize and efficiently use supplies to reduce the likelihood and mitigate the effects of future shortages
3	Develop explicit policies that give equal priority during a drug shortage to evidence-based use of chemotherapy agents whether patients are receiving treatment within or outside a clinical trial
4	Create an improved, centralized clearinghouse for sharing information about drug availability and shortages
5	Explore voluntary sharing of drugs at the state, regional, and national levels
6	Develop a strategy for ongoing stakeholder engagement regarding managing drug shortages, with specific emphasis on patients and patient advocacy groups